Huge Huge Huge Huge Post With NEW Information (HHHHPWNI

New Post Public Reply Private Reply Replies (5) Message Board
joey68
Huge Huge Huge Huge Post With NEW Information
(HHHHPWNI for short)
Did I mention this stuff is HUGE?

Note :
The links in this post may only work from the original board it was written.

I bet the majority of investors have never seen this stuff before!
I was doing some DD and surprisingly came across new stuff I never found before.

To start, I found the manual for the wavstat4. I cant wait to see the updated version of the manual!

Heres the English version of the manual:
http://www.spectrascience.com/images/uploads/..._Rev_B.pdf

Great read, and guess what? For the first time that ive ever seen (because we’ve heard of it, but how many people have actually seen it).. the manual shows the CE Mark on Page 2.

The actual CE mark is called ‘CE 0459’ which is standard. Perfect!

The manual even shows the BACK of the WavSTAT4 on page 10!

Reading through this manual, I google searched some key words and boom! Pow! Zing! All this new DD started slapping me in the face. I have a frozen bag of peas on my eye to help with the swelling.

Anyways..
Above the CE mark, it says ‘ EMERGO EUROPE’ .

Going to the EMERGO group website:
http://www.emergogroup.com/services/europe/ne...mbursement

it talks about Europe’s reimbursement programs. If you don’t know what this is, do some DD and youll figure it out.

Anyways.. EMERGOs site says:
Quote:

The Dutch medical device reimbursement process involves a diagnosis-related group (DRG) system known as the DBC used for patient classification and cost containment, as well as health technology assessments ( HTAs ) to determine cost-effectiveness of treatments.


Notice it mentions HTAs.

I googled "HTA" "spectrascience" and up pops this website:


http://deviceaccess.co.uk/

On the website, if you scroll down and watch the first video titled, “ Market Access & Reimbursement ”…

check out the speaker at :30 seconds! Its Hughes Wielemans of Spectrascience! In the video, he says SCIE is very interested in being adopted in the UK. Well, just listen to the video and hear it for yourself.

Did you hear Hughes say he asked Michael Branagan-Harris how to enter the UK market?

Michael Branagan-Harris Linkedin:
https://uk.linkedin.com/in/michael-branagan-harris-7b4a938

Quote:
“CEO Device Access UK Ltd-Market Access & Reimbursement Consultancy for MedTech & Diagnostic Devices into NHS England”


Hes the CEO of Device Access! Now scroll down to the bottom of the device access website, and look at their Client list!

Spectrascience is a client of theirs!! Do you see it? Its right there in PLAIN SIGHT! Im seriously not making this stuff up. Spectrascience is utilizing Device Access’s resources to penetrate the UK Market . And what does this mean? It means Spectrascience has been ACTIVELY working on entering the UK MARKET since 2014!

And remember, that video is from 2014 which means as of this post, we are 2 YEARS ahead of when this video was published.


Now go to 3:36 seconds in the video and hear him talk again. This is the best part!

He says that SCIE tried to enter the market on their own in the past and it made them lose 1 and a half years. Although this may sound bad, it’s not. It shows very typical growing pains. It’s very common for companies to try to save money by ‘doing things on their own’ only to figure out they need outside help. (..like you’ve never tried to do something on youre own, only to later realize you needed help. I know I have.)

This shows me that, instead of CONTINUING to try to do it on their own, SCIE admitted they needed help, and sought professional assistance from Device Access. This is great because it shows SCIE’s management was willing to admit they needed assistance.

MANY companies die off because they refuse to seek outside assistance. But not SCIE! Now they have the assistance of Device Access and again, seeing this video was from 2014, more than likely, they are 2 years closer to being marketable in the UK. This also helps build ‘good debt’. I talked about this in a previous post. ‘Good debt’ stems from the saying ‘it takes money to make money’. Any money SCIE spent on Device Access is going towards future profits. EXCELLENT!


BOOM! Even MORE proof Spectrascience hasn’t been sitting on their rump doing nothing for the past several years. Like I said a thousand times, it can take YEARS to penetrate the medical market in order to get your product developed, tested, approved, marketed, and distributed. And now, the majority of this stuff is in the PAST and whats the logical next step??

SALES!

In this 10K? Who knows! But who cares! Sales should be coming regardless of whether or not they show up in this 10K or the next 10Q or the next 10Q after that. As a long investor, it doesn’t matter to me because until I see evidence that this company is going to fail, im not going anywhere. Every corner I turn, I keep finding more and more evidence of a probable success story for Spectrascience, and now the story unfolds even more knowing SCIE has been actively working on selling their product in the UK with Device Access.

DD strikes again. DD:43 / Naysayers: 0

Note
Any blubbering response from naysayers which do not include links clearly stating SCIE is not working on penetrating the UK market will be ignored (you won’t find any).

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Haier and UEFA's Deal: A Game-Changer for Fans?

Updated Category News Views 1

A Bold Play in the Global Arena There's something big brewing on the horizon, as Haier aligns with the UEFA Champions League. From 2027 to 2031, this move isn't just about slapping a logo on a jersey. Nah, it's more than that. Haier's stepping up its game, aiming to become a real player in weaving technology and sports into the daily lives of millions. "We aim to bring...

Continue Reading
Cango's EcoHash Marks AI Move with Key Milestones

Updated Category News Views 4

AI Expansion at EcoHash: A Strategic Stride Some days you wake up, read a company pushing its legacy into something new, and you just gotta wonder if they’ve hit paydirt or just blowing smoke. For Cango Inc. and its subsidiary EcoHash, this latest update is shaping up interesting. They're no small potatoes in mining Bitcoins, but they're now trying their hand at AI...

Continue Reading
Windows Storage Trends Shift: SSD Dominates 2026

Updated Category News Views 0

SSDs Take Center Stage in Storage Evolution Howdy, storage folks! It's 2026, and one thing's for sure—SSDs are strutting their stuff at the top of the storage heap. According to the latest report by EaseUS Software, the dominant drive isn't about sheer size anymore. We've moved on to smarter space management. Now hear this: 79.73% of Windows system drives are rocking...

Continue Reading
Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

Updated Category News Views 2

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...

Continue Reading
PinkBlush Maternity Unveils Its 2026 Fall Fashion Line

Updated Category News Views 2

Elevating Maternity Fashion with PinkBlush's Fall 2026 Line You know, it's not every day you see maternitywear aiming to push the envelope, but that's exactly what PinkBlush is doing this fall. They've unleashed their Fall 2026 collection, and let's just say, it's less about the frills and more about redefining what expecting mothers can expect from the fashion world. A...

Continue Reading
PlugClaw: TrustKernel's AI Gadget Tackles Privacy Hurdles

Updated Category News Views 0

A Handy Revolution in AI Computing You know, every now and then, a gadget shows up that flips the scene on its head. Enter TrustKernel's PlugClaw. It's not every day you see a whole computer in something barely the size of your thumb, yet this one does exactly that. Weighing in at a measly 15 grams and armed with a MediaTek Helio G80, we're looking at a USB-C stick that's...

Continue Reading
PROCEPT Faces Legal Storm Over Sales Practices Missteps

Updated Category News Views 1

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Continue Reading
Perspecta's Study Reveals Troubling Data Accuracy Gaps

Updated Category News Views 2

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Continue Reading
Regeneron: Investors Face Class Action Over Study Flaws

Updated Category News Views 2

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Continue Reading
Lyntris Advances KSAT Hyperion Satellite Program Milestone

Updated Category News Views 1

Lyntris and KSAT: A Technological Feat in Space Connectivity Well, if it ain't Lyntris back in the headlines again, pushing the envelope on space connectivity. If you're keeping tabs on the space tech space, there's a cracker of a development brewing. Lyntris Inc. (NYSE: LYNX) just checked off a crucial box in their playbook—the Critical Design Review, or CDR for those...

Continue Reading

Top 5 Most Recently Viewed Articles

Trump's Inflation Claims: Markets Diverge Amid Mixed Signals

Updated Category News Views 144

On Presidents' Day, President Donald Trump touted a cooling economy and celebrated inflation dropping to an eight-month low of 2.4%. But while he proclaimed that prices are 'Way Down,' the reality shows some serious discrepancies that traders need to unpack. Inflation's Tug of War: The Real Numbers The Bureau of Labor Statistics delivered January's inflation rate at 2.4%,...

Continue Reading
Understanding the Recent Trends in United Airlines Short Interest

Updated Category News Views 165

Analyzing Recent Trends in United Airlines Holdings Inc's Short Interest United Airlines Holdings Inc (NYSE: UAL) has recently experienced a notable decrease in its short interest as a percentage of its outstanding shares. This metric has fallen by 6.22% according to the latest exchange data. Currently, there are approximately 11.17 million shares sold short, which...

Continue Reading
Comprehensive Overview of Recent Treasury Bill Auctions

Updated Category News Views 541

Recent Auction Results for Treasury Bills Understanding the results of treasury bill auctions is vital for anyone investing in fixed income securities. The auction results from the most recent activity showcase various key metrics that influence market dynamics. This article discusses these results in detail while analyzing the potential implications for investors. Key...

Continue Reading
Transocean Faces Setbacks Amid Market Shifts and Weather Trends

Updated Category News Views 124

Transocean Stock Performance Amid Market Changes Transocean Ltd (NYSE: RIG) has encountered a decline in its share price recently. As a key player in the offshore drilling sector, the company has felt the impact of significant shifts in the energy market due to geopolitical developments and weather forecasts. Market Influences on Transocean The turbulence in Transocean's...

Continue Reading
Discover the Magic of Short Shorts Film Festival 2025

Updated Category News Views 416

Short Shorts Film Festival & Asia 2025 Overview The Short Shorts Film Festival & Asia is renowned for its vibrant display of creativity and film artistry. In 2025, this highly esteemed festival will feature a remarkable lineup of approximately 250 films selected from an impressive 4,592 submissions. This diverse array of films captures the imagination and reflects the...

Continue Reading